Progress in DNA-based heterologous prime-boost immunization strategies for malaria

Immunological Reviews
A C Moore, Adrian V S Hill

Abstract

An effective vaccine against malaria is urgently required to relieve the immense human suffering and mortality caused by this parasite. A successful subunit vaccine against the liver stage of malaria will require the induction of high levels of protective T cells. Despite success in small animal models, DNA vaccines fail to induce strong cellular immune responses in humans. However, DNA vaccines can induce a T-cell response that can be strongly boosted by recombinant viral vectors. We have evaluated this heterologous prime-boost approach using the Plasmodium berghei mouse model for immunogenicity and protective efficacy against malaria challenge using combinations of plasmid DNA, recombinant modified vaccinia virus Ankara, fowlpox virus, and non-replicating adenovirus. We have proceeded to test immunogenicity and efficacy of successful heterologous prime-boost vaccines in phase I/IIa trials in malaria naïve subjects in the UK and in semi-immune individuals in The Gambia. In these clinical trials, remarkably high levels of effector T-cell responses have been induced and significant protection documented in a human sporozoite challenge model. We summarize the preclinical design and development of these heterologous prime-boost va...Continue Reading

References

May 1, 1992·Virology·J TartagliaM Riviere
Mar 1, 1990·The Journal of Experimental Medicine·W R WeissS L Hoffman
Mar 23, 1990·Science·J A WolffP L Felgner
Sep 1, 1991·Molecular and Biochemical Parasitology·V SatchidanandamB Moss
Nov 1, 1990·The Journal of Experimental Medicine·M TsujiF Zavala
Jan 1, 1987·Annual Review of Immunology·B Moss, C Flexner
Jan 1, 1989·Advances in Immunology·V Nussenzweig, R S Nussenzweig
Jan 1, 1989·Archives of Virology·C Kaplan
Nov 1, 1989·Transactions of the Royal Society of Tropical Medicine and Hygiene·J R DavisM M Levine
Jan 1, 1986·The American Journal of Tropical Medicine and Hygiene·J D ChulayW T Hockmeyer
Jan 1, 1982·Transactions of the Royal Society of Tropical Medicine and Hygiene·T PonnuduraiA H Lensen
Oct 11, 1994·Proceedings of the National Academy of Sciences of the United States of America·M SedegahS L Hoffman
Nov 14, 1997·Nature Biotechnology·S C GilbertA V Hill
Nov 15, 1997·Journal of the National Cancer Institute·K R IrvineN P Restifo
Feb 6, 1998·The American Journal of Tropical Medicine and Hygiene·K J RobsonA Crisanti
May 23, 1998·Annual Review of Immunology·M F GoodL H Miller
Nov 7, 1998·The Journal of Infectious Diseases·J A StouteW R Ballou
Jan 16, 1999·Advances in Experimental Medicine and Biology·L H MillerD C Kaslow
Feb 27, 1999·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·J J KimD B Weiner
Aug 17, 1999·Current Opinion in Immunology·M F Good, D L Doolan
Sep 22, 1999·Gene Therapy·N ChirmuleJ Wilson
Oct 3, 1999·Vaccine·J D BoyerD B Weiner

❮ Previous
Next ❯

Citations

Jul 28, 2005·Cancer Immunology, Immunotherapy : CII·Deborah J MarshallLinda A Snyder
Oct 13, 2006·Springer Seminars in Immunopathology·Lindvi GudmundsdotterBritta Wahren
Apr 18, 2008·Biotechnology Letters·Pieranna Chiarella, Vito Michele Fazio
May 7, 2009·Immunology and Cell Biology·Jack S Richards, James G Beeson
Apr 7, 2005·Nature Medicine·Stanley A Plotkin
Apr 7, 2005·Nature Medicine·Harriet L Robinson, Rama Rao Amara
Jan 26, 2008·Nature Reviews. Cancer·Jason RiceFreda K Stevenson
Dec 14, 2006·Molecular Therapy : the Journal of the American Society of Gene Therapy·Robert StraussAndré Lieber
Nov 1, 2007·Journal of Applied Animal Welfare Science : JAAWS·Andrew Knight
Jan 25, 2005·The Pediatric Infectious Disease Journal·Stanley A Plotkin
Oct 11, 2012·Genetic Vaccines and Therapy·Sarfraz AhmadMark Tangney
Dec 8, 2004·Genetic Vaccines and Therapy·Catherine Ivory, Kris Chadee
Aug 14, 2010·PLoS Neglected Tropical Diseases·Shivali Gupta, Nisha Jain Garg
Jun 1, 2011·PLoS Neglected Tropical Diseases·José E Aparicio-BurgosNisha Jain Garg
Jul 14, 2010·Expert Review of Vaccines·Mariana IngolottiDavid B Weiner
May 1, 2008·Expert Review of Vaccines·Rajeev K TyagiAbhinav Mehta
Feb 7, 2007·Expert Review of Vaccines·Anne C Moore, Claire L Hutchings
Dec 24, 2005·Expert Review of Vaccines·Jayne C Hope, H Martin Vordermeier
Jun 23, 2009·Expert Review of Vaccines·Silvia Inés CazorlaEmilio Luis Malchiodi
Aug 9, 2005·Expert Opinion on Emerging Drugs·W Ripley Ballou
Nov 22, 2005·Expert Opinion on Drug Delivery·H Oya AlparVincent W Bramwell
May 9, 2012·Journal of Controlled Release : Official Journal of the Controlled Release Society·Rajeev K TyagiTejram Sahu
Jun 10, 2009·Immunology Letters·Tomofumi UtoMasanori Baba
Mar 8, 2008·Advanced Drug Delivery Reviews·Laura J PeekCory Berkland
Sep 4, 2007·Comparative Immunology, Microbiology and Infectious Diseases·Jayne C Hope, Bernardo Villarreal-Ramos
May 12, 2005·Immunology·Stephen M Todryk, Michael Walther
Jun 1, 2006·The Journal of Pharmacy and Pharmacology·P J HogarthH M Vordermeier
Feb 24, 2006·The Veterinary Journal·H M VordermeierR G Hewinson

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Cell-Type-Specific Viral Vectors (ASM)

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

Cell-Type Specific Viral Vectors

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Cell-Type-Specific Viral Vectors

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.